Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026
NEW YORK, December 31, 2025, 17:16 ET — After-hours
- Eli Lilly shares eased in late trading as investors weighed fresh drug-pricing headlines.
- Attention stayed on early-2026 pricing resets in the U.S. and China for major diabetes and weight-loss medicines.
- U.S. markets are shut on New Year’s Day, putting the next full read on Friday’s session.
Eli Lilly and Co (LLY) shares slipped in after-hours trading on Wednesday. The stock was down about 0.5% at $1,074.68, after trading between $1,074.39 and $1,083.25 during the day on roughly 1.5 million shares.
Drug pricing has moved back to the center of the investment case for large-cap pharmaceuticals as Washington pushes for lower costs and companies adjust prices in overseas growth markets….
